These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 17357097)
1. Therapeutic neovascularization for peripheral arterial diseases: advances and perspectives. Zhou B; Poon MC; Pu WT; Han ZC Histol Histopathol; 2007 Jun; 22(6):677-86. PubMed ID: 17357097 [TBL] [Abstract][Full Text] [Related]
2. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases. Hung HS; Shyu WC; Tsai CH; Hsu SH; Lin SZ Cell Transplant; 2009; 18(9):1003-12. PubMed ID: 19650968 [TBL] [Abstract][Full Text] [Related]
3. [Angiogenesis and vasculogenesis. Therapeutic strategies for stimulation of postnatal neovascularization]. Kalka C; Asahara T; Krone W; Isner JM Herz; 2000 Sep; 25(6):611-22. PubMed ID: 11076319 [TBL] [Abstract][Full Text] [Related]
4. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation? Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208 [TBL] [Abstract][Full Text] [Related]
6. Growth factors for therapeutic angiogenesis in peripheral arterial disease. Jones WS; Annex BH Curr Opin Cardiol; 2007 Sep; 22(5):458-63. PubMed ID: 17762548 [TBL] [Abstract][Full Text] [Related]
7. Angiogenic growth factors in the treatment of peripheral arterial disease. Mikroulis D; Papanas N; Maltezos E; Bougioukas G Curr Vasc Pharmacol; 2007 Jul; 5(3):195-209. PubMed ID: 17627563 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease. Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic angiogenesis. Devising new strategies based on past experiences. Lei Y; Haider HKh; Shujia J; Sim ES Basic Res Cardiol; 2004 Mar; 99(2):121-32. PubMed ID: 14963670 [TBL] [Abstract][Full Text] [Related]
10. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. van Weel V; van Tongeren RB; van Hinsbergh VW; van Bockel JH; Quax PH Ann Vasc Surg; 2008; 22(4):582-97. PubMed ID: 18504100 [TBL] [Abstract][Full Text] [Related]
11. A balancing act: therapeutic approaches for the modulation of angiogenesis. Springer ML Curr Opin Investig Drugs; 2006 Mar; 7(3):243-50. PubMed ID: 16555684 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--Part II. Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M Cardiol Rev; 2008; 16(5):219-29. PubMed ID: 18708823 [TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia. Iwase T; Nagaya N; Fujii T; Itoh T; Ishibashi-Ueda H; Yamagishi M; Miyatake K; Matsumoto T; Kitamura S; Kangawa K Circulation; 2005 Jan; 111(3):356-62. PubMed ID: 15655128 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic angiogenesis through intramuscular injection of the gene for vascular endothelial growth factor (VEGF)]. Banga JD Ned Tijdschr Geneeskd; 2000 Jan; 144(3):113-6. PubMed ID: 10674116 [TBL] [Abstract][Full Text] [Related]